Vycor Medical, Inc. (VYCO)

Market Cap	2.27M -47.7%
Revenue (ttm)	1.81M +1.6%
Net Income	-384.30K
EPS	-0.01
Shares Out	33.37M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,000
Open	0.0393
Previous Close	0.0500
Day's Range	0.0393 - 0.0680
52-Week Range	0.0321 - 0.2000
Beta	-0.52
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 27, 2026

About Vycor Medical

Vycor Medical, Inc. designs, develops, and markets neurological medical devices and therapies in the United States and Europe. The company operates through two segments: Vycor Medical and NovaVision. Its Vycor Medical segment provides devices for neurosurgery comprising ViewSite Brain Access System, a retraction and access system for brain and spine surgeries. The NovaVision segment offers non-invasive computer-based rehabilitation therapies targeted at people who have impaired vision as a result of stroke or other brain injury. It has a licens...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2005
• Employees: 7
• Stock Exchange: OTCMKTS
• Ticker Symbol: VYCO

Financial Performance

In 2025, Vycor Medical's revenue was $1.86 million, an increase of 17.24% compared to the previous year's $1.59 million. Losses were -$396,796, -8.06% less than in 2024.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 20, 2026

Data Sources Report a data error